OSE Immunotherapeutics SA (ORPOF) Discusses Strategic Plan With Four Opportunities for Value Creation Transcript
PresentationFiona OlivierChief Corporate Affairs & Investor Relations Officer Good evening, and welcome to the webcast of OSE Immunotherapeutics. This evening, we're going to talk about the strategic plan that we announced yesterday. My name is Fiona Olivier. I'm Chief Corporate Affairs and Investor Relations Officer at OSE. And it's my pleasure to have Marc Le Bozec, our CEO; and Thomas Gidoin, who is our CFO. This discussion will be in French. There are a simultaneous translation into English. So feel fre ...